Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA does not grant orphan drug status to Levulan PDT for SCC prevention

Aug. 9, 2010

Glycotope begins phase I trial of GT-MAb 5.2-GEX in cancer

Aug. 9, 2010

Clavis advances phase II gemcitabine elaidate trial in pancreatic cancer

Aug. 9, 2010

Italian scientists identify new EGFR inhibitors

Aug. 9, 2010

Cornerstone Pharma adds new site for phase I/II CPI-613 trials in cancer

Aug. 9, 2010

Tekmira files IND application with FDA for PLK1-SNALP in solid tumors

Aug. 6, 2010

NIH provides grant for phase I/II AEZS-108 trial in advanced prostate cancer

Aug. 6, 2010

FDA approves new docetaxel injection concentrate formulation for cancer

Aug. 6, 2010

Gemin X secures funding for obatoclax development

Aug. 6, 2010

Bristol-Myers Squibb claims new JAK2 inhibitors

Aug. 6, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 1, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...